Extracorporeal membrane oxygenation (ECMO) is an important treatment option for organ support in respiratory insufficiency, cardiac failure, or as an advanced tool for cardiopulmonary resuscitation. Reports on pediatric ECMO use in our region are lacking.
Methods:
This study is a retrospective review of all pediatric cases that underwent a veno-arterial (VA) or veno-venous (VV) ECMO protocol between November 2009 and August 2020 at the Department of Pediatrics, University Hospital Center Zagreb, Croatia.
Results:
Fifty-two ECMO runs identified over the period; data were complete for 45 cases, of which 23 (51%) were female, and median age was 8 months. Thirty-eight (84%) patients were treated using the VA-and 7 (16%) using VV-ECMO. The overall survival rate was 51%. Circulatory failure was the most common indication for ECMO (N = 38, 84%), and in 17 patients ECMO was started after cardiopulmonary resuscitation (E-CPR). Among survivors, 74% had no or minor neurological sequelae. Variables associated with poor outcome were renal failure with renal replacement therapy (p < .001) and intracranial injury (p < .001).
Conclusion
Overall survival rate in our cohort is comparable to the data published in the literature. The use of hemodialysis was shown to be associated with higher mortality. High rates of full neurological recovery among survivors are a strong case for further ECMO program development in our institution.
BartlettRHGazzanigaABJefferiesMR, et al. Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infancy. Trans - Am Soc Artif Intern Organs1976; 22: 80–93.
ElmahroukAFIsmailMFHamoudaT, et al. Extracorporeal membrane oxygenation in postcardiotomy pediatric patients-15 years of experience outside Europe and North America. The Thorac Cardiovascular Surgeon2019; 67(1): 28–36. DOI: 10.1055/s-0037-1608962.
4.
Maslach-HubbardABrattonSL. Extracorporeal membrane oxygenation for pediatric respiratory failure: history, development and current status. World J Crit Care Med2013; 2(4): 29–39. DOI: 10.5492/wjccm.v2.i4.29.
5.
BrownKLIchordRMarinoBS, et al. Outcomes following extracorporeal membrane oxygenation in children with cardiac disease. Pediatr Crit Care Med2013; 14(5): S73–S83. DOI: 10.1097/pcc.0b013e318292e3fc.
6.
BakošMMatićTRubićF, et al. Rescue extracorporeal cardiopulmonary resuscitation in pediatric patients: a nine-year single-center experience in Zagreb, Croatia. Croat Medical Journal2021; 62(2): 146–153. DOI: 10.3325/cmj.2021.62.146.
7.
MelvanJNDavisJHeardM, et al. Factors associated with survival following extracorporeal cardiopulmonary resuscitation in children. World J Pediatr Congenit Heart Surg2020; 11(3): 265–274. DOI: 10.1177/2150135120902102.
8.
ErdilTLemmeFKonetzkaA, et al. Extracorporeal membrane oxygenation support in pediatrics. Ann Cardiothorac Surg2019; 8(1): 109–115. DOI: 10.21037/acs.2018.09.08.
9.
HenschLAHuiSKRTeruyaJ. Coagulation and bleeding management in pediatric extracorporeal membrane oxygenation: clinical scenarios and review. Front Med2019; 115: 361. DOI: 10.3389/fmed.2018.00361.
10.
FallonBPGadepalliSKHirschlRB. Pediatric and neonatal extracorporeal life support: current state and continuing evolution. Pediatr Surg Int2021; 37(1): 17–35. DOI: 10.1007/s00383-020-04800-2.
11.
MaticTBakosMBelinaD, et al. Extracorporeal membrane oxygenation after glenn procedure in a child with influenza B pneumonia. World J Pediatr Congenit Heart Surg2020; 11(3): 370–371. DOI: 10.1177/2150135119899619.
12.
BakosMDilberDBelinaD, et al. Extracorporeal cardiopulmonary resuscitation with low pump flow for blocked modified blalock-taussig shunt followed by spontaneous recanalization. Perfusion2021; 36(3): 305–307. DOI: 10.1177/0267659120946730.
13.
De TymowskiCAugustinPHouissaH, et al. CRRT connected to ECMO: managing high pressures. ASAIO J2017; 63(1): 48–52. DOI: 10.1097/MAT.0000000000000441.
14.
RoncoCGarzottoFBrendolanA, et al. Continuous renal replacement therapy in neonates and small infants: development and first-in-human use of a miniaturised machine (CARPEDIEM). The Lancet2014; 383: 1807–1813. DOI: 10.1016/S0140-6736(14)60799-6.
15.
RödlSMarschitzIMacheCJ, et al. Continuous renal replacement therapy with Prismaflex HF20 disposable set in children from 4 to 15 kg. ASAIO J2011; 57(5): 451–455. DOI: 10.1097/MAT.0b013e31822d2132.
16.
ChrysostomouCMaulTCallahanPM, et al. Neurodevelopmental outcomes after pediatric cardiac ECMO support. Front Pediatr2013; 1: 47. DOI: 10.3389/fped.2013.00047.
17.
JoffeARLequierLRobertsonCMT. Pediatric outcomes after extracorporeal membrane oxygenation for cardiac disease and for cardiac arrest: a review. ASAIO J2012; 58(4): 297–310. DOI: 10.1097/MAT.0b013e31825a21ff.
18.
ThouraniVHKirshbomPMKanterKR, et al. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) in pediatric cardiac support. Ann Thorac Surg2006; 82(1): 138–145. DOI: 10.1016/j.athoracsur.2006.02.011.
19.
KimHYangJHChoYH, et al. Outcomes of extracorporeal membrane oxygenation in children: an 11-year single-center experience in Korea. Korean J Thorac Cardiovasc Surg2017; 50(5): 317–325. DOI: 10.5090/kjtcs.2017.50.5.317.
20.
AlmondCSSinghTPGauvreauK, et al. Extracorporeal membrane oxygenation for bridge to heart transplantation among children in the United States. Circulation2011; 123(25): 2975–2984. DOI: 10.1161/CIRCULATIONAHA.110.991505.
21.
Bautista-HernandezVThiagarajanRRFynn-ThompsonF, et al. Preoperative extracorporeal membrane oxygenation as a bridge to cardiac surgery in children with congenital heart disease. Ann Thorac Surg2009; 88(4): 1306–1311. DOI: 10.1016/j.athoracsur.2009.06.074.
22.
FordMAGauvreauKMcMullanDM, et al. Factors associated with mortality in neonates requiring extracorporeal membrane oxygenation for cardiac indications. Pediatr Crit Care Med2016; 17(9): 860–870. DOI: 10.1097/PCC.0000000000000842.
23.
CashenKReederRDaltonHJ, et al. Functional status of neonatal and pediatric patients after extracorporeal membrane oxygenation. Pediatr Crit Care Med2017; 18(6): 561–570. DOI: 10.1097/PCC.0000000000001155.
24.
BarbaroRPPadenMLGunerYS, et al. Pediatric extracorporeal life support organization registry international report 2016. ASAIO J2018; 63(4): 456–463. DOI: 10.1097/MAT.0000000000000603.
25.
Rais-BahramiKvan MeursKP. Venoarterial versus venovenous ECMO for neonatal respiratory failure. Semin Perinatology2014; 38(2): 71–77. DOI: 10.1053/j.semperi.2013.11.003.
26.
BerdajsD. Bicaval dual-lumen cannula for venovenous extracorporeal membrane oxygenation: avalon cannula in childhood disease. Perfusion2015; 30(3): 182–186. DOI: 10.1177/0267659114544714.
27.
JarboeMDGadepalliSKChurchJT, et al. Avalon catheters in pediatric patients requiring ECMO: placement and migration problems. J Pediatr Surg2018; 53(1): 159–162. DOI: 10.1016/j.jpedsurg.2017.10.036.
28.
KimWKwonHWMinJ, et al. Extracorporeal membrane oxygenation in pediatric patients with respiratory failure: early experience with the double- lumen cannula over 2 years. Korean J Thorac Cardiovasc Surg2020; 53(3): 132–139. DOI: 10.5090/kjtcs.2020.53.3.132.
29.
SpeggiorinSRobinsonSGHarveyC, et al. Experience with the avalon bicaval double-lumen veno-venous cannula for neonatal respiratory ECMO. Perfusion2015; 30(3): 250–254. DOI: 10.1177/0267659114540020.
30.
CashenKMeertKDaltonH. Anticoagulation in neonatal ECMO: an enigma despite a lot of effort. Front Pediatr2019; 137: 366. DOI: 10.3389/fped.2019.00366.
31.
DownardCDBetitPChangRW, et al. Impact of AMICAR on hemorrhagic complications of ECMO: a ten-year review. J Pediatr Surg2003; 38(8): 1212–1216. DOI: 10.1016/s0022-3468(03)00270-7.
32.
Van Der StaakFHJDe HaanAFJGevenWB, et al. Surgical repair of congenital diaphragmatic hernia during extracorporeal membrane oxygenation: hemorrhagic complications and the effect of tranexamic acid. J Pediatr Surg1997; 32(4): 594–599. DOI: 10.1016/s0022-3468(97)90715-6.
33.
AskenaziDJAmbalavananNHamiltonK, et al. Acute kidney injury and renal replacement therapy independently predict mortality in neonatal and pediatric noncardiac patients on extracorporeal membrane oxygenation. Pediatr Crit Care Med2011; 12(1): e1–6. DOI: 10.1097/PCC.0b013e3181d8e348.
34.
FlemingGMSahayRZappitelliM, et al. The incidence of acute kidney injury and its effect on neonatal and pediatric extracorporeal membrane oxygenation outcomes. Pediatr Crit Care Med2016; 17(12): 1157–1169. DOI: 10.1097/PCC.0000000000000970.
35.
GoldsteinSLCurrierHWattersL, et al. Acute and chronic inflammation in pediatric patients receiving hemodialysis. J Pediatr2003; 143(5): 653–657. DOI: 10.1067/S0022-3476(03)00534-1.
36.
BetrusCRemenappRKudelkaT, et al. Enhanced hemolysis in pediatric patients requiring extracorporeal membrane oxygenation and continuous renal replacement therapy. Ann Thoracic Cardiovascular Surgery2007; 13(6): 378–383.
37.
FolandJAFortenberryJDWarshawBL, et al. Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis*. Crit Care Med2004; 32: 1771–1776. DOI: 10.1097/01.ccm.0000132897.52737.49.
38.
SutherlandSMZappitelliMAlexanderSR, et al. Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis2010; 55(2): 316–325. DOI: 10.1053/j.ajkd.2009.10.048.
39.
AlsoufiBAl-RadiOOGruenwaldC, et al. Extra-corporeal life support following cardiac surgery in children: analysis of risk factors and survival in a single institution. Eur J Cardio-Thoracic Surg2009; 35(6): 1004–1011. DOI: 10.1016/j.ejcts.2009.02.015.
40.
RaymondTTCunnynghamCBThompsonMT, et al. Outcomes among neonates, infants, and children after extracorporeal cardiopulmonary resuscitation for refractory in-hospital pediatric cardiac arrest: a report from the national registry of cardioPulmonary resuscitation*. Pediatr Crit Care Med2009; 11(3): 1–71. DOI: 10.1097/PCC.0b013e3181c0141b.
41.
PollackMMHolubkovRFunaiT, et al. Relationship between the functional status scale and the pediatric overall performance category and pediatric cerebral performance category scales. JAMA Pediatr2014; 168(7): 671–676. DOI: 10.1001/jamapediatrics.2013.5316.
42.
IJsselstijnHHunfeldMSchillerRM, et al. Improving long-term outcomes after extracorporeal membrane oxygenation: from observational follow-up programs toward risk stratification. Front Pediatr2018; 6: 177. DOI: 10.3389/fped.2018.00177.
43.
KumarTKSZurakowskiDDaltonH, et al. Extracorporeal membrane oxygenation in postcardiotomy patients: factors influencing outcome. J Thorac Cardiovasc Surg2010; 140(2): 330–336. DOI: 10.1016/j.jtcvs.2010.02.034.
44.
MorrisMCWernovskyGNadkarniVM. Survival outcomes after extracorporeal cardiopulmonary resuscitation instituted during active chest compressions following refractory in-hospital pediatric cardiac arrest. Pediatr Crit Care Med2004; 5(5): 440–446. DOI: 10.1097/01.pcc.0000137356.58150.2e.
